Viveca Nerme

591 total citations
21 papers, 488 citations indexed

About

Viveca Nerme is a scholar working on Molecular Biology, Animal Science and Zoology and Hematology. According to data from OpenAlex, Viveca Nerme has authored 21 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Animal Science and Zoology and 7 papers in Hematology. Recurrent topics in Viveca Nerme's work include Receptor Mechanisms and Signaling (8 papers), Pharmacological Effects and Assays (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Viveca Nerme is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Pharmacological Effects and Assays (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Viveca Nerme collaborates with scholars based in Sweden, Belgium and United States. Viveca Nerme's co-authors include Tommy Abrahamsson, Judith Leurs, Dirk Hendriks, Georges Vauquelin, J.J.J. van Giezen, K. Schatteman, Bengt Ek, Anders Hedberg, Petter Björquist and Per‐Ove Sjöquist and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Viveca Nerme

21 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viveca Nerme Sweden 15 210 199 116 113 56 21 488
Anne-Marie Marés France 12 107 0.5× 102 0.5× 34 0.3× 115 1.0× 63 1.1× 15 460
David C. B. Mills United States 11 276 1.3× 136 0.7× 20 0.2× 211 1.9× 72 1.3× 15 676
Shoji Kume Japan 14 278 1.3× 185 0.9× 18 0.2× 92 0.8× 35 0.6× 25 571
Sohei Tanabe Japan 14 134 0.6× 209 1.1× 65 0.6× 49 0.4× 37 0.7× 32 658
Jutta Meyer-Kirchrath Germany 15 47 0.2× 211 1.1× 63 0.5× 146 1.3× 20 0.4× 24 652
Lee C. Preusser United States 8 133 0.6× 290 1.5× 26 0.2× 96 0.8× 60 1.1× 11 544
MA Guccione Canada 12 273 1.3× 110 0.6× 30 0.3× 175 1.5× 37 0.7× 19 544
Thomas M. Coffman United States 8 84 0.4× 140 0.7× 15 0.1× 131 1.2× 29 0.5× 9 572
Yoji Shibayama United States 13 212 1.0× 183 0.9× 48 0.4× 51 0.5× 407 7.3× 23 818
Simbarashe Magwenzi United Kingdom 6 109 0.5× 143 0.7× 22 0.2× 135 1.2× 26 0.5× 6 414

Countries citing papers authored by Viveca Nerme

Since Specialization
Citations

This map shows the geographic impact of Viveca Nerme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viveca Nerme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viveca Nerme more than expected).

Fields of papers citing papers by Viveca Nerme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viveca Nerme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viveca Nerme. The network helps show where Viveca Nerme may publish in the future.

Co-authorship network of co-authors of Viveca Nerme

This figure shows the co-authorship network connecting the top 25 collaborators of Viveca Nerme. A scholar is included among the top collaborators of Viveca Nerme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viveca Nerme. Viveca Nerme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fjellström, Ola, Hans‐Georg Beisel, Per‐Olof Eriksson, et al.. (2015). Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design. PLoS ONE. 10(1). e0113705–e0113705. 27 indexed citations
2.
Fjellström, Ola, Johanna Deinum, Tove Sjögren, et al.. (2012). Characterization of a Small Molecule Inhibitor of Plasminogen Activator Inhibitor Type 1 That Accelerates the Transition into the Latent Conformation. Journal of Biological Chemistry. 288(2). 873–885. 26 indexed citations
3.
Abrahamsson, Tommy, et al.. (2005). Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis. Thrombosis Research. 116(6). 519–524. 18 indexed citations
4.
Leurs, Judith, et al.. (2004). Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold‐dependent mechanism. Journal of Thrombosis and Haemostasis. 2(3). 416–423. 89 indexed citations
5.
Leurs, Judith, et al.. (2003). Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma. Thrombosis and Haemostasis. 89(2). 264–271. 37 indexed citations
6.
Abrahamsson, Tommy, Viveca Nerme, K. Schatteman, et al.. (2002). Local proCPU (TAFI) Activation during Thrombolytic Treatment in a Dog Model of Coronary Artery Thrombosis can be Inhibited with a Direct, Small Molecule Thrombin Inhibitor (Melagatran). Thrombosis and Haemostasis. 87(4). 557–562. 23 indexed citations
7.
Giezen, J.J.J. van, Viveca Nerme, & Tommy Abrahamsson. (1998). PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood. Blood Coagulation & Fibrinolysis. 9(1). 11–18. 15 indexed citations
8.
Giezen, J.J.J. van, et al.. (1997). The Fab-fragment of a PAI-1 Inhibiting Antibody Reduces Thrombus Size and Restores Blood Flow in a Rat Model of Arterial Thrombosis. Thrombosis and Haemostasis. 77(5). 964–969. 41 indexed citations
9.
Abrahamsson, Tommy, et al.. (1996). Anti-thrombotic Effect of a PAI-1 Inhibitor in Rats Given Endotoxin. Thrombosis and Haemostasis. 75(1). 118–126. 33 indexed citations
10.
Abrahamsson, Tommy, et al.. (1994). An antibody ragment against PAI-1 inhibits PAI-1 activity and stimulates fibrinolysis in vitro and in vivo. Fibrinolysis and Proteolysis. 8. 55–56. 10 indexed citations
11.
Nerme, Viveca, et al.. (1990). The β1 and β2‐adrenoceptor affinity and β1‐blocking potency of S‐ and R‐metoprolol. British Journal of Pharmacology. 99(3). 592–596. 28 indexed citations
12.
Nerme, Viveca, Tommy Abrahamsson, & Georges Vauquelin. (1990). Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.. Journal of Pharmacology and Experimental Therapeutics. 252(3). 1341–1346. 21 indexed citations
13.
Reid, Julianne J., et al.. (1990). (+)-Sotalol causes significant occupation of ?-adrenoceptors at concentrations that prolong cardiac repolarization. Naunyn-Schmiedeberg s Archives of Pharmacology. 341(3). 215–20. 13 indexed citations
14.
Abrahamsson, Tommy, Bengt Ek, & Viveca Nerme. (1988). The β1- and β2-adrenoceptor affinity of atenolol and metoprolol. Biochemical Pharmacology. 37(2). 203–208. 22 indexed citations
15.
Abrahamsson, Tommy & Viveca Nerme. (1987). β1‐ and β2‐Adrenoceptor Affinity and Stimulatory Effects of (S)‐Pindolol and Iodinated (S)‐Pindolol. Pharmacology & Toxicology. 60(2). 120–124. 3 indexed citations
16.
IJzerman, Adriaan P., et al.. (1987). Shallow agonist competition binding curves for beta-adrenergic receptors: the role of tight agonist binding.. Molecular Pharmacology. 31(1). 69–73. 23 indexed citations
17.
Nerme, Viveca, et al.. (1986). Spontaneous coupling of the beta-adrenergic receptor to Ns in mammalian cardiac membranes.. Molecular Pharmacology. 30(1). 1–5. 7 indexed citations
18.
Dahl�f, C., Anders Hedberg, & Viveca Nerme. (1986). Evidence for prejunctionally located ?2-adrenoceptors in the cat spleen. Naunyn-Schmiedeberg s Archives of Pharmacology. 333(4). 362–367. 8 indexed citations
19.
Nerme, Viveca, et al.. (1985). Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding. Biochemical Pharmacology. 34(16). 2917–2922. 23 indexed citations
20.
Hedberg, Anders, H. Mattsson, Viveca Nerme, & Enar Carlsson. (1984). Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat. Naunyn-Schmiedeberg s Archives of Pharmacology. 325(3). 251–258. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne-Marie Marés Breakdown of academic impact, for papers by David C. B. Mills Breakdown of academic impact, for papers by Shoji Kume Breakdown of academic impact, for papers by Sohei Tanabe Breakdown of academic impact, for papers by Jutta Meyer-Kirchrath Breakdown of academic impact, for papers by Lee C. Preusser Breakdown of academic impact, for papers by MA Guccione Breakdown of academic impact, for papers by Thomas M. Coffman Breakdown of academic impact, for papers by Yoji Shibayama Breakdown of academic impact, for papers by Simbarashe Magwenzi
Rankless by CCL
2026